Grantee Spotlight: Luis G. Carvajal-Carmona, PhD

| January 19, 2018 | 0 Comments
Grantee Spotlight: Luis G. Carvajal-Carmona, PhD

Dr. Carvajal-Carmona is an Associate Professor and CRCHD R21 awardee researching cancer genetics, epidemiology, and cancer health disparities.

See Original Article

RAS Pathway v3.0?

Defining the most important elements of RAS signaling is an important objective of the NCI RAS Initiative. In a new RAS Dialogue post, advisor Frank McCormick invites community input on version 3.0 of the RAS Pathway.
See Original Article

Long-Term Nerve Damage Possible after Chemotherapy for Breast Cancer

Many women who receive taxane-based chemotherapy to treat breast cancer experience long-term nerve damage, or peripheral neuropathy, data from a large clinical trial show.
See Original Article

Category: Recent News

About the Author ()

Leave a Reply